Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
13.21
-0.09 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pliant Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -201.68 | -161.34 | -123.32 | -97.26 | -41.53 | -0.63 | |
Depreciation & Amortization | 2.13 | 1.84 | 1.82 | 1.54 | 1.31 | 1.11 | |
Loss (Gain) From Sale of Investments | 7.17 | -4.99 | -1.81 | 1.26 | - | - | |
Stock-Based Compensation | 38.36 | 44.48 | 22.6 | 10.44 | 3.9 | 1.83 | |
Other Operating Activities | 3.2 | 2.39 | 1.86 | 1.67 | 0.27 | - | |
Change in Accounts Receivable | - | 1.98 | 0.02 | 7.28 | -2.23 | -7.05 | |
Change in Accounts Payable | 3.53 | 2.97 | -1.35 | 0.89 | 0.92 | -1.26 | |
Change in Other Net Operating Assets | 14.35 | -3.7 | 5.55 | -1.26 | -0.15 | 3.08 | |
Operating Cash Flow | -132.94 | -116.36 | -94.63 | -75.44 | -37.27 | -2.75 | |
Capital Expenditures | -3.7 | -0.92 | -1.76 | -1.95 | -1.53 | -0.96 | |
Investment in Securities | 136.83 | -126.09 | -148.44 | 75.65 | -209.33 | -16.97 | |
Investing Cash Flow | 133.13 | -127.01 | -150.2 | 73.7 | -210.87 | -17.93 | |
Long-Term Debt Issued | - | - | 10 | - | - | - | |
Net Debt Issued (Repaid) | 19.91 | - | 10 | - | - | - | |
Issuance of Common Stock | 3.34 | 275.25 | 217.56 | 2.98 | 161.19 | 0.17 | |
Other Financing Activities | -0.01 | -0.85 | -0.71 | -0.46 | - | -2.58 | |
Financing Cash Flow | 23.23 | 274.41 | 226.85 | 2.53 | 213.21 | 45.54 | |
Net Cash Flow | 23.42 | 31.03 | -17.98 | 0.78 | -34.93 | 24.86 | |
Free Cash Flow | -136.64 | -117.28 | -96.39 | -77.4 | -38.8 | -3.71 | |
Free Cash Flow Margin | - | -7422.91% | -995.26% | -1022.13% | -92.79% | -6.51% | |
Free Cash Flow Per Share | -2.27 | -2.00 | -2.29 | -2.16 | -1.82 | -2.29 | |
Cash Interest Paid | 2.14 | 1.15 | 0.62 | - | - | - | |
Levered Free Cash Flow | -84.08 | -66.86 | -51.12 | -42.56 | -23.66 | -4.05 | |
Unlevered Free Cash Flow | -82.51 | -66.07 | -50.62 | -42.56 | -23.66 | -4.05 | |
Change in Net Working Capital | -19.5 | -3.62 | -6.22 | -8.38 | 1.31 | 5.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.